Loading...
Forte Biosciences Inc (FBRX) is not a strong buy for a beginner, long-term investor at this moment. The technical indicators are neutral, there are no significant trading trends or positive catalysts, and the financial performance remains weak with negative EPS and net income. Additionally, no proprietary trading signals or recent news suggest a compelling entry point.
The MACD is below 0 and negatively contracting, indicating a lack of bullish momentum. RSI is neutral at 48.619, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 29.79, with resistance at 32.128 and support at 27.452.

NULL identified. No recent news, no significant trading trends, and no proprietary trading signals.
and net income (-$17.68M). Lack of significant insider or hedge fund activity. No recent congress trading data or influential figure transactions.
In Q3 2025, revenue remained at $0 with no YoY growth. Net income improved by 110.70% YoY but remains negative at -$17.68M. EPS dropped significantly by -78.19% YoY to -0.99.
No data available for analyst ratings or price target changes.